Bolt Biotherapeutics Inc
NASDAQ:BOLT

Watchlist Manager
Bolt Biotherapeutics Inc Logo
Bolt Biotherapeutics Inc
NASDAQ:BOLT
Watchlist
Price: 5.24 USD -6.43% Market Closed
Market Cap: 10.1m USD

Intrinsic Value

The intrinsic value of one BOLT stock under the Base Case scenario is 0.74 USD. Compared to the current market price of 5.24 USD, Bolt Biotherapeutics Inc is Overvalued by 86%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BOLT Intrinsic Value
0.74 USD
Overvaluation 86%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Bolt Biotherapeutics Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about BOLT?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is BOLT valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Bolt Biotherapeutics Inc.

Explain Valuation
Compare BOLT to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about BOLT?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Bolt Biotherapeutics Inc

Current Assets 35.6m
Cash & Short-Term Investments 31.9m
Other Current Assets 3.7m
Non-Current Assets 29.4m
Long-Term Investments 6.9m
PP&E 21.4m
Other Non-Current Assets 1.2m
Current Liabilities 10m
Accounts Payable 1.5m
Accrued Liabilities 6.5m
Other Current Liabilities 1.9m
Non-Current Liabilities 23m
Other Non-Current Liabilities 23m
Efficiency

Free Cash Flow Analysis
Bolt Biotherapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Bolt Biotherapeutics Inc

Revenue
5.2m USD
Operating Expenses
-49.9m USD
Operating Income
-44.7m USD
Other Expenses
2m USD
Net Income
-42.7m USD
Fundamental Scores

BOLT Profitability Score
Profitability Due Diligence

Bolt Biotherapeutics Inc's profitability score is 17/100. The higher the profitability score, the more profitable the company is.

17/100
Profitability
Score

Bolt Biotherapeutics Inc's profitability score is 17/100. The higher the profitability score, the more profitable the company is.

BOLT Solvency Score
Solvency Due Diligence

Bolt Biotherapeutics Inc's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
55/100
Solvency
Score

Bolt Biotherapeutics Inc's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BOLT Price Targets Summary
Bolt Biotherapeutics Inc

Wall Street analysts forecast BOLT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BOLT is 27.29 USD with a low forecast of 5.05 USD and a high forecast of 78.75 USD.

Lowest
Price Target
5.05 USD
4% Downside
Average
Price Target
27.29 USD
421% Upside
Highest
Price Target
78.75 USD
1 403% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Bolt Biotherapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for BOLT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

BOLT Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one BOLT stock?

The intrinsic value of one BOLT stock under the Base Case scenario is 0.74 USD.

Is BOLT stock undervalued or overvalued?

Compared to the current market price of 5.24 USD, Bolt Biotherapeutics Inc is Overvalued by 86%.

Back to Top